The Lancet on Twitter: "A stent-free treatment for small coronary artery disease: findings from the BASKET-SMALL 2 trial https://t.co/TmyfwF5jDD Register now to read #ESCCongress #LancetCardiology for free up to Sept 10! https://t.co/uwFWpsqp4R
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial - The Lancet
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial - The Lancet
Drug Coated Balloons safer than Drug Eluting Stents for small vessel coronary artery disease, confirms a BASKET-SMALL 2 trial
Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial
Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial | SpringerLink
Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial | JACC: Cardiovascular Interventions
Trial Scorecard: BASKET-SMALL 2
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial - The Lancet
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial
BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease | tctmd.com
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial - The Lancet
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial | Circulation: Cardiovascular Interventions
Drug-coated Balloons or Drug-eluting Stents – Determining an Optimum Strategy for Patients with High Bleeding Risk – touchCARDIO
Drug-Coated Balloons in Small Coronary Artery Disease - Docwire News
Drug-Coated Balloons for Small Coronary Artery Disease: BASKET-SMALL 2 - ppt download
Frontiers | Appropriate Surrogate Endpoint in Drug-Coated Balloon Trials for Coronary Artery Diseases
BASKET-SMALL 2 Trial: DCBs Significantly Lowered Revascularization in Diabetics vs. DES - CRTonline
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial - The Lancet
Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review | Journal of the American College of Cardiology
Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review - ScienceDirect
Sultania Cardiovascular Sciences - BASKET SMALL 2 Trial Among patients undergoing PCI in small arteries, the use of a drug-coated balloon was noninferior to a drug-eluting stent. The drug-coated balloon was noninferior
